AIM ImmunoTech, Inc. (AIM)

0.8526 -0.12 (-12.15%) USD  |  NYAM  |  Mar 25, 16:00
0.704 -0.15 (-17.43%) After-Hours: 20:00
More

AIM ImmunoTech Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. --
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade
Enzon Pharmaceuticals, Inc. --